Qiagen Stock
Qiagen Stock price
Key metrics
Create a Free Account to create an Qiagen alert.
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
Qiagen Stock Analysis
Analyst Opinions
24 Analysts have issued a Qiagen forecast:
Analyst Opinions
24 Analysts have issued a Qiagen forecast:
Financial data from Qiagen
| Dec '24 |
+/-
%
|
||
| Revenue | 1,700 1,700 |
1%
1%
|
|
| Gross Profit | 1,085 1,085 |
2%
2%
|
|
| EBITDA | 434 434 |
11%
11%
|
EBIT (Operating Income) EBIT | 425 425 |
11%
11%
|
| Net Profit | 72 72 |
76%
76%
|
|
In millions EUR.
Don't miss a Thing! We will send you all news about Qiagen directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
| Head office | United States |
| CEO | Thierry Bernard |
| Employees | 5,232 |
| Founded | 1996 |
| Website | www.qiagen.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
